Type 2 Diabetes Mellitus: A Comprehensive Review of Pathophysiology, Comorbidities, and Emerging Therapies
Aditi Singh,
No information about this author
Sucharita Shadangi,
No information about this author
Pulkit Kr. Gupta
No information about this author
et al.
Comprehensive physiology,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: Feb. 1, 2025
ABSTRACT
Humans
are
perhaps
evolutionarily
engineered
to
get
deeply
addicted
sugar,
as
it
not
only
provides
energy
but
also
helps
in
storing
fats,
which
survival
during
starvation.
Additionally,
sugars
(glucose
and
fructose)
stimulate
the
feel‐good
factor,
they
trigger
secretion
of
serotonin
dopamine
brain,
associated
with
reward
sensation,
uplifting
mood
general.
However,
when
consumed
excess,
contributes
imbalance,
weight
gain,
obesity,
leading
onset
a
complex
metabolic
disorder,
generally
referred
diabetes.
Type
2
diabetes
mellitus
(T2DM)
is
one
most
prevalent
forms
diabetes,
nearly
affecting
all
age
groups.
T2DM
clinically
diagnosed
cardinal
sign
chronic
hyperglycemia
(excessive
sugar
blood).
Chronic
hyperglycemia,
coupled
dysfunctions
pancreatic
β‐cells,
insulin
resistance,
immune
inflammation,
further
exacerbate
pathology
T2DM.
Uncontrolled
T2DM,
major
public
health
concern,
significantly
toward
progression
several
micro‐
macrovascular
diseases,
such
diabetic
retinopathy,
nephropathy,
neuropathy,
atherosclerosis,
cardiovascular
including
cancer.
The
current
review
discusses
epidemiology,
causative
factors,
pathophysiology,
comorbidities,
existing
emerging
therapies
related
It
future
roadmap
for
alternative
drug
discovery
management
Language: Английский
Exploring the Significance of Gut Microbiota in Diabetes Pathogenesis and Management—A Narrative Review
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(12), P. 1938 - 1938
Published: June 19, 2024
Type
2
diabetes
is
a
disease
with
significant
health
consequences
for
the
individual.
Currently,
new
mechanisms
and
therapeutic
approaches
that
may
affect
this
are
being
sought.
One
of
them
association
type
microbiota.
Through
enteric
nervous
system
gut–microbiota
axis,
microbiota
affects
functioning
body.
It
has
been
proven
to
have
real
impact
on
influencing
glucose
lipid
metabolism
insulin
sensitivity.
With
dysbiosis,
there
increased
bacterial
translocation
through
disrupted
intestinal
barrier
inflammation
in
In
diabetes,
microbiota’s
composition
altered
with,
example,
more
abundant
class
Betaproteobacteria.
The
these
disorders
linked
involving
short-chain
fatty
acids,
branched-chain
amino
lipopolysaccharide,
among
others.
Interventions
focusing
gut
gaining
traction
as
promising
approach
management.
Studies
currently
conducted
effects
supply
probiotics
prebiotics,
well
fecal
transplantation,
course
diabetes.
Further
research
will
allow
us
fully
develop
our
knowledge
subject
possibly
best
treat
prevent
Language: Английский
Next-Generation Probiotics and Chronic Diseases: A Review of Current Research and Future Directions
Ashutosh Tiwari,
No information about this author
Dyah Ika Krisnawati,
No information about this author
Erna Susilowati
No information about this author
et al.
Journal of Agricultural and Food Chemistry,
Journal Year:
2024,
Volume and Issue:
72(50), P. 27679 - 27700
Published: Nov. 26, 2024
The
burgeoning
field
of
microbiome
research
has
profoundly
reshaped
our
comprehension
human
health,
particularly
highlighting
the
potential
probiotics
and
fecal
microbiota
transplantation
(FMT)
as
therapeutic
interventions.
While
benefits
traditional
are
well-recognized,
efficacy
mechanisms
remain
ambiguous,
FMT's
long-term
effects
still
being
investigated.
Recent
advancements
in
high-throughput
sequencing
have
identified
gut
microbes
with
significant
health
benefits,
paving
way
for
next-generation
(NGPs).
These
NGPs,
engineered
through
synthetic
biology
bioinformatics,
designed
to
address
specific
disease
states
enhanced
stability
viability.
This
review
synthesizes
current
on
NGP
stability,
challenges
delivery,
their
applications
preventing
treating
chronic
diseases
such
diabetes,
obesity,
cardiovascular
diseases.
We
explore
physiological
characteristics,
safety
profiles,
action
various
strains
while
also
addressing
opportunities
presented
by
integration
into
clinical
practice.
NGPs
revolutionize
microbiome-based
therapies
improve
outcomes
is
immense,
underscoring
need
further
optimize
ensure
safety.
Language: Английский
Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in DN
J. Liu,
No information about this author
Min Guo,
No information about this author
Xiaobin Yuan
No information about this author
et al.
Journal of Diabetes,
Journal Year:
2025,
Volume and Issue:
17(4)
Published: April 1, 2025
ABSTRACT
Background
Diabetic
nephropathy
(DN)
is
a
severe
microvascular
complication
of
diabetes
with
complex
pathogenesis.
Methods
Recent
studies
were
reviewed
to
explore
the
role
gut
microbiota
and
its
metabolites
in
DN
development.
Results
Dysbiosis
bacteria
contributes
pathological
changes
such
as
glomerular
sclerosis
renal
tubule
injury.
Microbial
are
involved
through
immune
inflammatory
pathways.
Conclusions
Understanding
relationship
between
microbiota,
metabolites,
may
offer
potential
implications
for
diagnosis,
prevention,
treatment.
Translating
this
knowledge
into
clinical
practice
presents
challenges
opportunities.
Language: Английский
Ultrasonic degradation of mulberry twigs polysaccharides: Effect on in vitro hypoglycemic activity and prebiotic potential
Yanan Jia,
No information about this author
Qiaoyu Li,
No information about this author
Fenglin Jiang
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 143356 - 143356
Published: April 1, 2025
Language: Английский
Modulating gut microbiota in the management of type 2 diabetes mellitus: a narrative review
Meirajuddin Tousif,
No information about this author
Maria Akhtar
No information about this author
International Journal of Research in Medical Sciences,
Journal Year:
2024,
Volume and Issue:
12(6), P. 2179 - 2185
Published: May 31, 2024
Type
2
diabetes
mellitus
(T2DM)
represents
a
significant
global
health
burden,
necessitating
innovative
therapeutic
approaches.
Recent
research
has
increasingly
recognized
the
role
of
gut
microbiota
modulation
in
T2DM
management,
offering
promising
avenues
for
intervention.
This
systematic
review
synthesizes
current
literature
investigating
impact
modulating
on
management.
A
comprehensive
search
databases
yielded
studies
examining
various
strategies,
including
probiotics,
prebiotics,
dietary
interventions,
and
facal
transplantation.
Analysis
these
interventions
revealed
their
potential
to
improve
glycemic
control,
insulin
sensitivity,
inflammation
markers
individuals
with
T2DM.
Mechanistic
insights
elucidate
how
influences
metabolic
pathways,
immune
function,
barrier
integrity,
thereby
contributing
pathophysiology.
Furthermore,
highlight
interplay
between
composition
host
factors
such
as
diet,
lifestyle,
genetics,
underscoring
complexity
this
relationship.
Modulating
presents
approach
benefits
control
health.
However,
further
is
warranted
optimize
intervention
mechanistic
explore
long-term
effects.
The
aim
was
underscores
importance
considering
complementary
multifaceted
management
Language: Английский
Analyzing Amylin Aggregation Inhibition Through Quantum Dot Fluorescence Imaging
Xiaoyu Yin,
No information about this author
Ziwei Liu,
No information about this author
Gegentuya Huanood
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(20), P. 11132 - 11132
Published: Oct. 17, 2024
Protein
aggregation
is
associated
with
various
diseases
caused
by
protein
misfolding.
Among
them,
amylin
deposition
a
prominent
feature
of
type
2
diabetes.
At
present,
the
mechanism
remains
unclear,
and
this
has
hindered
treatment
In
study,
we
analyzed
process
using
quantum
dot
(QD)
imaging
method.
QD
fluorescence
revealed
that
in
presence
100
μM
amylin,
aggregates
appeared
after
12
h
incubation,
while
large
number
formed
24
standard
deviation
(SD)
value
5.435.
contrast,
50
did
not
induce
formation
although
were
observed
an
SD
2.883.
Confocal
laser
microscopy
observations
these
deposited
three
dimensions.
Transmission
electron
existed
as
misfolded
fibrils
vitro
QDs
uniformly
bound
to
fibrils.
addition,
microliter-scale
high-throughput
screening
(MSHTS)
system,
found
rosmarinic
acid,
polyphenol,
inhibited
at
half-maximal
effective
concentration
852.8
μM.
These
results
demonstrate
MSHTS
system
powerful
tool
for
evaluating
inhibitory
activity
aggregation.
Our
findings
will
contribute
understanding
pathogenesis
amylin-related
discovery
compounds
may
be
useful
prevention
diseases.
Language: Английский